fee-for-service Medicare at the time of the index acute ischemic stroke admission, to evaluate the independent associations of different levels of eGFR and being on dialysis, with 30-day and 1-year mortality and rehospitalizations. We also studied the relationships of other patient and hospital characteristics with these outcomes stratified by the level of kidney dysfunction.
Methods
Supporting data are available within the article and its online-only Data Supplement.
Patient Population
We used data on Medicare fee-for-service patients admitted with ischemic stroke between 2009 and 2014 from GWTG-Stroke that were linked to Centers for Medicare and Medicaid Services claims for long-term outcomes. Details of the GWTG-Stroke program have been previously published. 10 Medicare-aged GWTG-Stroke ischemic stroke patients are generally representative of the national fee-forservice Medicare ischemic stroke population. 11 Quintiles Real-World & Late Phase Research (Cambridge, MA) served as the data collection and coordination center for GWTG. The Duke Clinical Research Institute (Durham, NC) served as the data analysis center. 10 Each participating hospital received either human research approval to enroll patients without individual patient consent under the common rule or a waiver of authorization and exemption from subsequent review by their institutional review board. Institutional review board approval was obtained for this study. A total of 300 768 patients with ischemic stroke who were discharged alive and who had records linked to Centers for Medicare and Medicaid Services claims data were identified. From the 249 586 patients eligible for the study, 44 934 were excluded because of missing race, creatinine, or extreme creatinine values that were not medically plausible. After relevant exclusions, 204 652 patients aged 65 years and older with ischemic stroke from 1579 GWTG-Stroke fully participating sites who were discharged alive were included in the analysis (Figure) . The eGFR levels were selected based on chronic kidney disease (CKD) 
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Outcomes
Poststroke mortality and rehospitalization were ascertained from information available from Centers for Medicare and Medicaid Services data.
Covariates
The GWTG standard covariates for the adjusted analysis of the association of admission eGFR with 30-day and 1-year mortality and rehospitalizations included (1) demographics: age, sex, and race; (2) medical history: atrial fibrillation/flutter, previous stroke/transient ischemic attack, coronary artery disease/prior myocardial infarction, carotid stenosis, diabetes mellitus, peripheral vascular disease, hypertension, dyslipidemia, and smoking; (3) other patient characteristics: arrival on versus off hours (regular hours: 7 am-6 pm, Monday-Friday), initial National Institutes of Health Stroke Scale (NIHSS) score; and (4) hospital characteristics such as region, hospital type (teaching/ nonteaching), number of beds, annual ischemic stroke volume, annual intravenous tPA (tissue-type plasminogen activator) volume, rural location, and Joint Commission stroke center status.
Variables that were included in the interaction analysis with admission eGFR were selected a priori based on their possible association with stroke outcomes and included, in addition to the above variables, initial systolic blood pressure, glucose level, LDL (low-density lipoprotein)-cholesterol, independent ambulatory status at admission, medications at discharge, in-hospital procedures and complications, intravenous tPA administration, and symptomatic intracranial hemorrhage <36 hours from intravenous tPA administration for patients who received intravenous tPA, discharge location, smoking cessation advice or counseling, stroke education, stroke rehabilitation, and weight recommendation.
Statistical Analysis
Patient and hospital characteristics were summarized and compared by eGFR groups and dialysis status using proportions for categorical variables and medians with 25th and 75th percentiles for continuous variables. Differences across eGFR/dialysis groups were compared using Pearson χ 2 tests, Fisher exact test, or Kruskal-Wallis tests as appropriate. Kaplan-Meier estimates and log-rank tests describe and compare unadjusted rates across groups. The relationship between eGFR groups and patient outcomes was assessed with Cox proportional hazards models starting at patient discharge alive. Robust sandwich estimates of the covariance were used to account for potential clustering of patients within hospitals. Multivariable adjustment was performed with the standard GWTG-Stroke adjustment list and potential confounders. Patients were administratively censored at 30 days or 1 year for applicable models or if there was a change in Medicare fee-for-service status. Nonmortality outcomes were censored at the time of mortality to estimate cause-specific hazard ratios (HRs). Results are reported for an overall test across eGFR groups (global P value) and with pairwise group comparisons as HR with 95% CI and P values with the eGFR ≥60 group as reference.
In a separate analysis, we assessed whether eGFR modified the association of patient and hospital factors with outcomes using Cox proportional hazards models. For each factor, we report the interaction P value; a significant interaction (P<0.05) suggests that eGFR level modifies the relationship between the factor and outcome. In such situations, the HR and 95% CI between the factor and outcome are provided for each eGFR category, estimated from the model with fitted interactions.
Functional forms of continuous variables were assessed using lack-of-fit tests comparing a linear fit with a restricted cubic spline fit. If nonlinearity was found, appropriate transformations were used, including piecewise linear splines to approximate the nonlinearity while balancing interpretability. Proportional hazards assumptions were assessed by plotting the cumulative martingale residuals and appropriate transformations made when applicable. Colinearity between covariates was assessed using variance inflation factors; no colinearity of the variables was suggested. Multiple imputation (25 imputations) was used to estimate missing data except for initial NIHSS and hospital characteristics where a complete case analysis was performed. The missing rates for most patient characteristics were <1%, except NIHSS, which was missing 38% of cases. Baseline characteristics of those with NIHSS documented were compared with those of missing NIHSS. Most hospital characteristics were available, except for hospital type (0.28% missing) and number of beds (0.30% missing). If a patient had missing medical history, it was assumed that the medical conditions did not occur as abstractors were likely to skip the section when none applied. The characteristics of subjects included in the study were compared with patients who were excluded based on missing race, creatinine, or creatinine values that are not medically plausible. Data were analyzed using SAS version 9.3 (SAS Institute, Cary, NC). All tests were 2-sided with P values <0.05 indicating statistical significance, unadjusted for multiple comparisons.
Sensitivity Analyses
To determine whether the findings would be similar using other equations for the calculation of eGFR, a sensitivity analysis of the association of eGFR with mortality and rehospitalization was performed using another commonly used method for estimating eGFR, the CKDEpidemiology Collaboration equation in which eGFR=141×min (Scr /κ, 1) α×max (Scr /κ, 1)-1.209×0.993 Age×1.018 (if female)×1.159 (if black); Scr is serum creatinine in mg/dL, κ is 0.7 for females and 0.9 for males, α is −0.329 for females and −0.411 for males, min indicates the minimum of Scr /κ or 1, and max indicates the maximum of Scr /κ or 1.
Because admission eGFR may be caused by acute renal dysfunction and not always reflect CKD, sensitivity analyses were performed to determine the association of eGFR and dialysis with outcomes limited to patients who also have ICD-9-CM codes reflecting CKD identified by the following codes: 585.3 (CKD stage 3), 585.4 (CKD stage 4), 585.5 (CKD stage 5 excluding patients requiring chronic dialysis), 585.6 (end-stage renal disease requiring chronic dialysis), and 585.9 (CKD unknown/unspecified).
Results
Of 204 652 patients discharged alive, 48.8% had an eGFR ≥60, 26.5% eGFR 45 to 59, 16.3% eGFR 30 to 44, 5.1% eGFR 15 to 29, 0.6% eGFR <15 without dialysis, and 2.8% were receiving dialysis. Of the total cohort, 5% died within 30 days, 23% died within 1 year, 14 % were rehospitalized within 30 days, and 48% were rehospitalized within 1 year. Characteristics of the initial cohort and hospital characteristics are described by eGFR categories in Table1; Tables I and II in the online-only Data Supplement. Subjects on dialysis were more likely than other eGFR groups to be non-white, to have previous stroke/transient ischemic attack, coronary artery disease/prior myocardial infarction, carotid stenosis, diabetes mellitus, peripheral vascular disease, hypertension, dyslipidemia, heart failure, and to be on antiplatelet, lipid-lowering, or diabetes mellitus medication. The characteristics of subjects excluded based on missing race, creatinine, or extreme creatinine values are described in Table III . Compared with subjects without missing NIHSS, those with missing NIHSS had longer stroke onset to ED arrival, lower rates of smoking cessation counseling, stroke education, or weight recommendation (Table IV) . A higher percentage of missing NIHSS was noted in smaller hospitals with lower numbers of strokes admissions and annual intravenous tPA administration, in the South or Northeast, rural and without primary stroke center status (Table V) .
The cumulative incidence of mortality within 1 year of discharge was higher as the eGFR decreased ( Figure I in the online-only Data Supplement; Table 2 ). On multivariable analysis, eGFR <15 without dialysis was associated with the highest 30-day mortality (HR, 2.09; 95% CI, 1.66-2.63; P<0.0001). Being on dialysis was associated 
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with the highest 1-year mortality (HR, 2.65; 95% CI, 2.49-2.81; Table 2 ). The rate of rehospitalization within 1 year after discharge was higher as the eGFR decreased ( Figure II in the onlineonly Data Supplement; Table 3 ). On multivariable analysis, dialysis was associated with the highest 30-day and 1-year rehospitalization rates (HR, 2.10; 95% CI, 1.95-2.26 and HR, 2.55; 95% CI, 2.44-2.66, respectively; Table 3 ).
The composite of mortality and rehospitalization within 1 year after discharge among ischemic stroke patients was also higher as the eGFR decreased ( Figure III in the onlineonly Data Supplement; Table 4 ). On multivariable analysis, dialysis was associated with the highest 30-day and 1-year composite of mortality and rehospitalization (HR, 2.04; 95% CI, 1.90-2.18 and HR, 2.46; 95% CI, 2.36-2.56, respectively; Table 4 ).
Adjusted sensitivity analysis using the CKD-Epidemiology Collaboration equation resulted in reclassification of 0.9% of the cohort to an eGFR <60 (eGFR >60, 47.9%; eGFR 45-59, 25.2%; eGFR 30-44, 17.1%; eGFR 15-29, 6.3%; eGFR <15, 0.8%; and dialysis, 2.8%) and revealed similar association of eGFR with mortality and rehospitalizations (Tables VI and VII ).
An adjusted sensitivity analysis restricted to patients who also had CKD identified by ICD-9-CM codes revealed that compared with eGFR ≥60 with ICD-9-CM suggestive of CKD, an eGFR <30 remained associated with increased 30-day and 1-year mortality, 30-day and 1-year rehospitalization, and 30-day and 1-year composite mortality and rehospitalizations (Tables VIII through X ). An eGFR <15 was associated with the highest 30-days composite of mortality and rehospitalization (HR, 1.63; 95% CI, 1.34-1.98) and dialysis was associated with the highest 1-year composite of mortality and rehospitalization (HR, 1.74; 95% CI, 1.62-1.85; Table X ).
The associations of several demographic and clinical factors with 30-day and 1-year composite of mortality and rehospitalization varied by the level of kidney dysfunction (Figures IV and V in the online-only Data Supplement). The effects of most of the included factors on outcomes were weakened with advanced kidney dysfunction. For example, age and an increase in the NIHSS score were associated with an increase in composite 30-day and 1-year mortality and rehospitalization regardless of eGFR, but the association was lowest among those on dialysis. The association of atrial fibrillation/ flutter did not vary by the level of kidney function for 30-day outcomes but was highest in those with eGFR >15 for 1-year outcomes. The association of anticoagulation with 30-day or 1-year outcomes did not vary by the level of kidney function. In contrast, a history of smoking in patients on dialysis was associated with an increased risk of mortality and rehospitalization at 1-year whereas the effect of smoking in other eGFR categories was less significant. Being a woman was associated with worse poststroke outcomes only in dialysis patients.
Compared with other levels of kidney dysfunction, patients on dialysis who had a symptomatic intracranial hemorrhage within 36-hours of treatment with intravenous tPA had the highest 1-year mortality and rehospitalizations (HR, 7.51; 95% CI, 2.79-20.22; P<0.0001).
Discussion
In this nationwide study of Medicare beneficiaries aged ≥65 years with acute ischemic stroke, after adjusting for relevant clinical and demographic factors, eGFR and dialysis status on admission were strong predictors of outcomes and modified the relationship of other clinical and demographic factors with 30-day and 1-year mortality and rehospitalizations. In adjusted models, 30-day mortality was highest among patients with eGFR <15 without dialysis with about 2× higher odds compared with those with eGFR ≥60. In contrast, 1-year mortality, 30-day and 1-year rehospitalizations, and 30-day and 1-year combined mortality and rehospitalizations were highest among those on dialysis with at least 2× higher odds for any of these outcomes. These findings further extend and strengthen previous studies suggesting that renal dysfunction may be associated with increased poststroke mortality. 8, 13, 14 Reduced admission creatinine clearance, high serum creatinine, and higher urea concentrations poststroke were associated with a higher risk of all-cause mortality during a 7-year follow-up period. 15 In a study of a Chinese cohort with type 2 diabetes mellitus, low eGFR <45 mL/min per 1.73 m 2 was a predictor of 1-year poststroke all-cause mortality. 6 In another study, acute kidney injury following acute ischemic stroke was an independent predictor of 10-year mortality. 16 In contrast, albuminuria but not eGFR was found in some studies to be associated with poststroke mortality. 3, 5 None of these studies separately analyzed those on dialysis or based classifications according to the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative.
Data about the association of kidney dysfunction and rehospitalizations is scarce. In some studies, renal disease was included in models for hospital readmissions in stroke patients and was found to be associated with higher readmissions; however, these studies did not analyze the level of renal dysfunction and dialysis status. 9, 17, 18 In contrast, we found a strong, graded association of impaired renal function with 30-day and 1-year all-cause rehospitalizations that were independent of other factors. Patients receiving dialysis had the highest risk of rehospitalization at both 30-days and 1-year.
The association of kidney dysfunction with poststroke outcomes may be because of several possible factors. Renal impairment in patients with stroke may indicate end-organ damage from common risk factors, such as uncontrolled hypertension or other comorbidities. 15 Alternatively, renal impairment may cause endothelial dysfunction, homocystenemia, coagulation disorders, impaired endothelial release of tPA, extravascular coagulation, and higher levels of inflammatory cytokines and oxidative stress. 19, 20 Our findings suggest the importance of including kidney dysfunction and especially dialysis status as predictors of rehospitalizations and mortality both at 30-days and 1-year. Future studies should evaluate whether targeted interventions directed towards this high-risk group reduces mortality and rehospitalizations.
We also found that the association of several patients and hospital-level characteristics with outcomes varied by eGFR. Overall, the association of multiple factors with outcomes tended to lessen among those on dialysis, potentially reflecting unmeasured confounders or a stronger association of outcomes with dialysis. Some of the interactions may be because of chance (multiple testing) or may not be clinically important. In contrast, the significant increased risk of 1-year mortality and rehospitalization in dialysis patients who develop symptomatic 
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intracranial hemorrhage may be related to unmeasured comorbidities, significant hemostatic dysfunction, or poorer functional outcomes. It is possible that the finding of increased risk of worse outcome in women on dialysis is because of poorer previous functional status and other comorbidities. We think that these results are interesting in that they identify other important predictors of outcomes in the setting of kidney dysfunction. More studies are needed to duplicate these findings and determine the reasons behind these interactions. Adjusted sensitivity analysis restricted to patients who also had CKD identified by ICD-9-CM codes revealed that eGFR <30 (but not ≥30) and being on dialysis remained associated with poststroke outcomes. This may be because of ICD-9 codes underestimating the prevalence of CKD or because the comparator was eGFR ≥60 with a diagnosis of CKD. 21 It is also possible that the effect of acute kidney injury on poststroke outcomes is different than established kidney disease.
This study has limitations. The data are limited to GWTGStroke participating hospitals and the Medicare population (aged ≥65 years) and may not be generalizable to younger populations. GWTG-Stroke data, however, are generally representative of national fee-for-service Medicare ischemic stroke populations. 11 In addition, about 95% percent of individuals ≥65 years use Medicare in the United States.
22 Although generally valid, dialysis was identified based on ICD-9-CM codes, which may underestimate its true prevalence. 23 Unmeasured confounding cannot be excluded. Admission creatinine was not obtained in all patients introducing a possible selection bias, however, the difference in the other baseline characteristics of those included versus excluded from the study based on admission creatinine was small. A time-dependent analysis was not performed because creatinine was only available during the hospital admission. The modification of diet in renal disease formula for calculating eGFR may not be entirely accurate in the setting of acute ischemic stroke. A sensitivity analysis using the CKD-Epidemiology Collaboration equation, however, yielded similar results. Albuminuria and proteinuria data are not available in the GWTG database, which may explain why some subjects with eGFR ≥60 have a diagnosis of CKD. NIHSS was missing in 38% of the cases and not at random; however, the difference between baseline characteristics of those missing NIHSS versus not was modest, and possible confounding variables were adjusted for in multivariable analyses. There was no correction for multiple testing. Finally, cause-specific mortality was not available.
Among older patients hospitalized with acute ischemic stroke who survived to discharge, a lower eGFR and dialysis on admission were independently associated with a higher 30-day and 1-year mortality and rehospitalizations suggesting that kidney function should be included in risk-stratification models for poststroke outcomes.
